China Pharma Holdings (CPHI) Profit After Tax (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Profit After Tax came in at -$709562.0 in Q1 2026, up 9.68% YoY from -$646963.4 in Q1 2025, and up 40.25% on a QoQ basis from -$1.2 million in Q4 2025.
China Pharma Holdings (CPHI) Profit After Tax (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Profit After Tax data on file, last reported at -$709562.0 in Q1 2026.
- Quarterly Profit After Tax rose 9.68% year-over-year to -$709562.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (up 31.81% YoY) and the FY2025 annual result came in at -$3.2 million, up 32.7% from the prior year.
- Profit After Tax advanced to -$709562.0 in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$475976.0 in Q1 2023 to a low of -$2.3 million in Q4 2022.
- A 5-year average of -$952905.4 and a median of -$888394.0 in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax plunged 142.51% — and 2025, when it jumped 63.26%.
- Tracing CPHI's Profit After Tax over 5 years: stood at -$2.3 million in 2022, then soared by 56.31% to -$985250.0 in 2023, then declined by 24.28% to -$1.2 million in 2024, then grew by 3.01% to -$1.2 million in 2025, then soared by 40.25% to -$709562.0 in 2026.
- The last three Profit After Tax figures came in at -$709562.0 (Q1 2026), -$1.2 million (Q4 2025), and -$594147.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -709,562.00 |
| Dec 31, 2025 | -1.19 Mn |
| Sep 30, 2025 | -594,147.00 |
| Jun 30, 2025 | -528,367.00 |
| Mar 31, 2025 | -785,572.00 |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -980,273.00 |
| Jun 30, 2024 | -1.44 Mn |
| Mar 31, 2024 | -955,892.00 |
| Dec 31, 2023 | -985,250.00 |
| Sep 30, 2023 | -777,600.00 |
| Jun 30, 2023 | -593,029.00 |
| Mar 31, 2023 | -475,976.00 |
| Dec 31, 2022 | -2.25 Mn |
| Sep 30, 2022 | -790,773.00 |
| Jun 30, 2022 | -888,394.00 |
| Mar 31, 2022 | -1.03 Mn |
| Dec 31, 2021 | -980,719.00 |
| Sep 30, 2021 | -826,669.00 |
| Jun 30, 2021 | -824,761.00 |